Austin Miller, PhD

Austin Miller, PhD

Research Assistant Professor, Department of Biostatistics

Contact Information

RSC - 522
Roswell Park Cancer Institute
Phone: 716-845-4029
Fax: 716-845-4860
Email: austin.miller@roswellpark.org

 

Research Interests:   The design and analysis of experimental, clinical and observational studies, measurement error models and structural equations modeling

 

Selected Publications

  • Rungruang B, Miller A, Richard SD, Hamilton CA, Rodriguez N, Bookman MA, Maxwell GL, Krivak TC, Horowitz NS.  Should stage IIC ovarian cancer be further stratified by intraperitoneal vs. retroperitoneal only disease?:  A Gynecologic Oncology Group study.  Gynecologic Oncology 2012; 124(1):53-58
  • Nwogu CE, Groman A, Fahey D, Yendamuri S, Dexter E, Demmy TL, Miller A, Reid M.  Number of lymph nodes and metastatic lymlph node ratio are associated with survival in lung cancer.  Annals of Thoracic Surgery 2012; 93(5):1614-1619; discussion 1619-1620
  • Odunsi K, Matsuzaki J, Karbach J, Neumann A, Mhawech-Fauceglia P, Miller A, Beck A, Morrison Cd, Ritter G, Godoy H, Lele S, DuPont N, Edwards R, Shrikant P, Old LJ, Gnjatic S, Jager E.  Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients.  Proceedings of the National Academy of Sciences of the United States of America 2012; 109(15):5797-5802
  • Richard S, Miller A, Markman M. Armstrong D, Walker J, Krivak T.  Nadir CA125 and second look surgery in patients with advanced stage epithelial ovarian cancer treated with intravenous compared to intraperitoneal chemotherapy:  A study of Gynecologic Oncology Group Protocols 114 and 172.  Gynecologic 2012; 125(Suppl. 1):S28-S29
  • Rodriquez N, Miller A, Richard S, Rungruang B, Hamilton C, Bookman M, Maxwell G, Horowtiz N, Krivak T.  Upper abdominal prcoedures in advanced stage ovarian or primary peritoneal carcinoma patients with minimal or no gross residuial disease:  An analysis of GOG 12. Gynecologic Oncology 2012; 125(Suppl.1):S23-S24
  • Rungruang B, Miller A, Richard S, Rodriguez N, Bookman M, Hamilton C, Maxwell G, Horowitz N, Krivak T.  Advamced stage ovarian cancer - Does complex surgery improve survival?  An analysis of GOG 182.  Gynecologic Oncology 2012; 125(Suppl. 1):S23
  • Allamaneni SS, Sharma R, Miller A, Yendamuri SS, Gibbs JF.  Additional primary malignancies in patients with pancreatic cancer:  2012 Gasrointenstional Cancers Symposium.  Journal of Clinical Oncology 2012; 30(4 Suppl.):Abstract #185
  • O'Cearbhaill RE, Miller A, Muggia F, Smith JA, Bookman MA, Sabbatini P, Gynecologic Oncology Group.  Carboplatin dosing in the treatment of epithelial ovarian cancer (EOC):  A Gynecologic Oncology Group (GOG) study:  ASCO Meeting Abstracts Part 1.  Journal of Clinical Oncology 2012; 30(15 Suppl.):Abstract #5041
  • Yendamuri S, Caty L, Pine M, Adem S, Bogner P, Miller A, Demmy Tl, Groman A, Reid M.  Outcomes of sarcomatoid carcinoma of the lung:  A Surveillance, Epidemiology, and End Results database analysis.  Surgery 2012; 152(3):397-402